Latest filing published 27 Jan 2023 for Enfusion, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Steven M. Bachert: trading record in brief
Steven M. Bachert discloses dealings in Enfusion, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 25 October 2022 to 25 January 2023.
No open-market purchase appears, only 1 sale worth €345k. The rest of the record consists of 2 share grants.
Most recently, on 27 January 2023, the filings show a share grant in Enfusion, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Steven M. Bachert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,739 shares0Class A Common StockSEC:0001104659-23-007631:0
- 26,000 shares@ US$13.69100.0% of flowClass A Common StockSEC:0001104659-22-119543:0
- 35,739 shares0Class A Common StockSEC:0001104659-22-112114:0
3 of 3 declarations